Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis (GKT137831)

A placebo-controlled, multicenter, randomized trial to test GKT137831 in ambulatory patients with idiopathic pulmonary fibrosis. This drug is an inhibitor of nicotinamide adenine dinucleotide

pulmonary disease
idiopathic pulmonary fibrosis
forced vital capacity
  • 27 views
  • 02 May, 2022
  • 1 location
Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).

Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease marked by reduced exercise capacity and activity-related breathlessness (commonly termed dyspnea). Our previous work has shown

nitric oxide
idiopathic pulmonary fibrosis
Accepts healthy volunteers
cardiopulmonary exercise testing
interstitial lung disease
  • 0 views
  • 06 May, 2022
  • 1 location
IPF mHealth Exercise

Patients with idiopathic pulmonary fibrosis (IPF) who are stable on antifibrotic therapy at least 3 months will be randomized to complete a 12-week home exercise intervention using an mHealth

pirfenidone
carbon monoxide
diffusion capacity of the lung for carbon monoxide
a 12
nintedanib
  • 0 views
  • 18 Oct, 2021
  • 1 location
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis

changes over time in Idiopathic Pulmonary Fibrosis (IPF) patients receiving approved IPF treatments. Subjects will undergo an approximately hour long comprehensive MRI protocol, including

ct scan
pirfenidone
idiopathic pulmonary fibrosis
nintedanib
pulmonary function test
  • 4 views
  • 18 May, 2022
  • 1 location
Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

up to 28 days in adult subjects with idiopathic pulmonary fibrosis (IPF) alone or in conjunction with local Standard of Care for IPF (pirfenidone or nintedanib). A maximum of 24 evaluable

esbriet
pirfenidone
nintedanib
lung biopsy
pneumonia
  • 4 views
  • 11 Oct, 2022
  • 11 locations
Jaktinib Dihydrochloride Monohydrate in Idiopathic Pulmonary Fibrosis

Jaktinib Dihydrochloride Monohydrate for idiopathic pulmonary fibrosis

acetylcysteine
idiopathic pulmonary fibrosis
  • 35 views
  • 10 Dec, 2021
  • 1 location
Effect of Continuous Positive Airway Pressure (CPAP) on Abnormal Gastroesophageal Reflux and Lung Inflammation in Idiopathic Pulmonary Fibrosis (IPF)

This study will evaluate the effect of CPAP therapy on esophageal pH and lung inflammation in patients with idiopathic pulmonary fibrosis (IPF) and sleep apnea.

idiopathic pulmonary fibrosis
nintedanib
  • 0 views
  • 13 Oct, 2022
  • 1 location
Phase ll Study of HEC585 in Patients With IPF

A Phase ll Study to evaluate the efficacy and safety of various doses of HEC585 Tablets in patients with idiopathic pulmonary fibrosis

idiopathic pulmonary fibrosis
pirfenidone
diffusion capacity of the lung for carbon monoxide
  • 0 views
  • 08 Oct, 2021
  • 1 location
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

tomography (PET/CT) will show lung inflammation and fibrosis in patients diagnosed with idiopathic pulmonary fibrosis (IPF). This study may help physicians and researchers better understand how best to treat

positron emission tomography
idiopathic pulmonary fibrosis
forced vital capacity
  • 0 views
  • 20 Jun, 2022
  • 1 location
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

This trial is a multi-centre, open-label, single-arm phase 2 trial investigating the safety, efficacy and pharmacokinetics of C21 in subjects with idiopathic pulmonary fibrosis.

emphysema
idiopathic pulmonary fibrosis
  • 0 views
  • 05 Jul, 2022
  • 14 locations